$0.070
(0%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 12 November 2026 at 9:04am | ||||
RHINOMED LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (12-Nov) $11,471,000 (1,037th) |
Close (30-Jun) $0.070 |
Volume (30-Jun) 0 |
Shortsold (8-Jan) 4,400 (0.00%) (473rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.04 |
Trading update, BTNX Agreement and Rights issue
RNO released this announcement to the ASX on 7 April 2022, 9:23. The announcement is not marked as price sensitive, and is 32 page(s) in length and 4.17MB in size.
You can view all announcements from RNO and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RNO | |
|---|---|
| Change in substantial holding WG | 18 May 2023, 9:23 |
| App 3Y MJ | 4 May 2023, 10:56 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 9:19 |
| Trading update, BTNX Agreement and Rights issue | 7 April 2022, 9:23 |
| Non-Renounceable Issue | 7 April 2022, 9:23 |
| BTNX Supply Agreement | 7 April 2022, 9:23 |
| Trading Halt | 7 April 2022, 8:32 |
If you were already registered, log in here.
If you were already registered, log in here.